Top News
Latest News
INNOVATION
31 Oct 2025
CRISPR Pushes Closer to One-Shot Genetic Cures
CRISPR’s CTX460 shows strong AATD results, edging gene therapy closer to one-shot cures
TECHNOLOGY
29 Oct 2025
Coding the Cure: Lilly and Verve Team Up on Gene Editing
The $1.3 billion Verve deal expands Lilly’s reach into gene editing and next-generation heart therapies
PARTNERSHIPS
28 Oct 2025
One Infant, One Breakthrough: CRISPR Enters a New Phase
Acuitas, CHOP, and Penn pioneer safer, patient-tailored base editing through a landmark CRISPR collaboration
MARKET TRENDS
7 Aug 2025
Gene Editing’s Next Battle: Cracking the Delivery Code
Biotech firms like Intellia and Editas race to crack CRISPR delivery, a key to market dominance and future gene therapy breakthroughs.
INVESTMENT
30 Jul 2025
Lilly Bets $1.3B on One-Shot Cure for Heart Disease
Lilly buys Verve Therapeutics to chase a one-time gene edit that could end lifelong cholesterol treatment.
TECHNOLOGY
16 Jul 2025
AI and CRISPR: A Partnership Set to Rewrite Biotech
AI is reshaping how CRISPR therapies reach cells, cutting delays and boosting safety in the race for next-gen gene editing.
topics on the agenda
VERSATILITY OF TRANSCRIPTION FACTORS AS GENE EDITING TARGETS FOR PRECISION ONCOLOGY
DAY 1: undefined
09:40 - 10:05
THE CRISPR LANDSCAPE: REGULATIONS AND PAYOR OUTLOOK EVOLUTIONS
DAY 1: undefined
11:30 - 11:55
PRE-CLINICAL RESEARCH TO CLINICAL PROGRAMS: GRNA MANUFACTURING & GENOME EDITING
DAY 1: undefined
13:30 - 13:55
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.